去年在多發性硬化症藥物Tysabri 併發多灶性白質腦病變(PML)的統計

引述自：

Tysabri PML Stats for 2010

Tuesday January 4, 2011

As of December 2010, there have been 79 reported cases of progressive multifocal leukoencephalopathy (PML) linked to Tysabri (natalizumab). Sixteen of these people have died as a result of PML.

去年（2010）共有79例有白質腦病變（關聯Tysabri ），其中有16位死亡。

This is up significantly from a year ago. At the beginning of December 2009, the total number of PML cases was "only" 28, with 5 of those people dying.

數據遠比2009年還高出許多，驟增。2009/12時，只有28例有白質腦病變（關聯Tysabri ）其中有5位死亡。

Part of the increase in PML is attributed to the fact that more people are passing the 2-year mark for infusions. The risk of PML appears to increase from approximately .01 per 1000 in people receiving 12 infusions or less to more than 2.05 per 1000 in people who have received more than 24 infusions.

更多資訊如下：

Here’s what I have:
82 total, with

35 US

40 EU
5 ROW

Here’s the link to the website where I get my info. It seems to be the definitive source for Tysabri/PML info

http://chefarztfrau.de/?page_id=716

國外藥物的發展狀況：供大家參考

相關延伸閱讀：

關注自己的身體: Multiple Sclerosis 多發性硬化症: 台灣衛生署核准...

關注自己的身體: Multiple Sclerosis 多發性硬化症: 諾華藥廠的...

Biogen報告Tysabri藥物服用者出現第七例多灶性白質腦病病例...

去年在多發性硬化症藥物Tysabri 併發多灶性白質腦病變(PML)的統計